Point Man On Protein Science

Harvard Researcher Timothy Springer’s Lifetime Of Advocacy For An Essential – But Often Neglected – Driver of New Drug Development

In this latest edition of the Lab Links series on notable figures responsible for major advances in drug discovery, In Vivo talks to Harvard Medical School professor and biologist Timothy Springer on his 50-year record as an academic scientist, business entrepreneur and philanthropist. His latest venture is being co-founder – and principal funder – of the independent non-profit Institute for Protein Innovation, an institution designed to fill a critical niche in open-source biomedical research.

Springer_Timonthy_1200.jpg
"Mentorship is one of the most important ways of ensuring great science continues to grow." - Timothy Springer

As an academic biochemist, Timothy Springer has authored original insights on the structure, function and interactions of biomedically important proteins: one 1990 paper, on the cell recognition molecules that drive immune response, has been cited in peer review more than 10,000 times. His work has shaped medical practice in key fields like immunology, inflammation, hematology and infectious diseases, accomplishments reflected in the clinic through at least four blockbuster drugs, all now available to patients worldwide. Though a skeptic at first, Springer has also emerged as a savvy start-up entrepreneur, earning outsize returns as a founder and investor in seven biotech companies, gains he has now applied as an advocacy philanthropist testing new business models to plug research silos, address unmet medical needs and promote the open-source dissemination of knowledge.

All told, Springer has the receptive mind of a true explorer: who else could relate the physical properties of a...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Leadership

More from In Vivo